Hannah Valantine
Director · 4 filings · Latest: Jun 12, 2026
BridgeBio Pharma, Inc.
CareDx, Inc.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BBIO | HANNAH A VALANTINE | — | Jun 22, 2026 | Proposed Sale | $68.00 | 2,808 | $190.9K | — | |
CDNA | Hannah Valantine | Director | Jun 15, 2026 | Sale | $23.11 | 12,103 | $279.7K | 36,686 | |
CDNA | HANNAH VALANTINE | — | Jun 15, 2026 | Proposed Sale | $22.97 | 12,103 | $278.0K | — | |
BBIO | Hannah Valantine | Director | Mar 10, 2026 | Sale | $72.00 | 8,671 | $624.3K | 7,465 | |
BBIO | Hannah Valantine | Director | Mar 10, 2026 | Option Exercise | $27.36 | 8,671 | $237.2K | 16,136 | |
BBIO | HANNAH A VALANTINE | — | Mar 10, 2026 | Proposed Sale | $72.00 | 8,671 | $624.3K | — | |
BBIO | Hannah Valantine | Director | Feb 27, 2026 | Sale | $67.41 | 25,484 | $1.7M | 7,465 | |
BBIO | Hannah Valantine | Director | Feb 27, 2026 | Option Exercise | $48.45 | 25,484 | $1.2M | 32,949 | |
BBIO | HANNAH A VALANTINE | — | Feb 27, 2026 | Proposed Sale | $67.41 | 25,484 | $1.7M | — | |
BBIO | Hannah A Valantine | — | Nov 12, 2025 | Proposed Sale | $66.07 | 25,484 | $1.7M | — | |
BBIO | DENIS VON KAEPPLER IRA ROLLOVER | — | Jun 26, 2025 | Proposed Sale | $44.03 | 1,891 | $83.3K | — | |
BBIO | HANNAH VALANTINE & DENIS VON KAEPPLER | — | Jun 26, 2025 | Proposed Sale | $44.01 | 1,542 | $67.9K | — | |
BBIO | HANNAH A VALANTINE & DENIS VON KAEPPLER JT TEN | — | Jun 26, 2025 | Proposed Sale | $44.11 | 876 | $38.6K | — | |
BBIO | ERICKA VON KAEPPLER & DENIS VON KAEPPLER JT TEN | — | Jun 26, 2025 | Proposed Sale | $44.13 | 398 | $17.6K | — | |
CDNA | HANNAH VALANTINE | — | Jun 18, 2025 | Proposed Sale | $19.52 | 10,570 | $206.3K | — | |
BBIO | HANNAH A VALANTINE | — | Jun 10, 2025 | Proposed Sale | $40.00 | 4,292 | $171.7K | — | |
BBIO | HANNAH A VALANTINE | — | Mar 6, 2025 | Proposed Sale | $32.58 | 12,875 | $419.5K | — |